Dexcom Moves Quickly To Tango With Medtronic In Next-Gen Glucose Testing
This article was originally published in The Gray Sheet
Executive Summary
Eager to hasten adoption of its second-to-market STS continuous glucose monitoring system, DexCom plans to embark any day on a nationwide launch of the just-approved device
You may also be interested in...
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
Dexcom Makes Final Preparations On Seven-Day Glucose Monitor Submission
Dexcom plans to submit a PMA supplement for its seven-day STS continuous glucose monitoring system by the end of June